Rash at the injection site after tirzepatide: deciding what to do next

The most likely explanation: a local skin reaction, not an allergy

When a small red mark or raised patch appears around where you injected, the first thing to know is that this is not unusual. The NHS medicines page for tirzepatide lists injection-site reactions among the common side effects, meaning they affect a meaningful proportion of people, especially in the early weeks. The skin is reacting to the physical disruption of the needle or to the medicine itself passing through the subcutaneous tissue.

These local reactions tend to be small, usually no wider than a coin, and limited to the injection spot. You might notice mild redness, a faint raised welt, slight warmth, or itching. In most cases the mark fades within a few hours. It does not mean something has gone wrong and, for most people, it does not mean tirzepatide is unsuitable for them. A cold, clean compress held gently against the area for a few minutes after injecting is often enough.

If you are regularly noticing reactions and wondering whether technique is a factor, it is worth reviewing how you are injecting. Guidance on the full injection process, including site rotation, is covered on our tirzepatide injection guide. Rotating properly (abdomen, thigh, and upper arm in turn) gives each area time to recover between doses.

When the rash looks more concerning: signals that need a clinical eye

Some skin changes after injecting tirzepatide do warrant calling someone. A reaction that keeps growing in size over 24 to 48 hours, feels hot and hard to the touch, or develops a weeping centre could indicate a localised infection, particularly if you have been injecting into the same spot repeatedly. That is a conversation for your GP or prescriber the same day.

Hives that spread beyond the injection area, swelling of the lips, face or throat, dizziness, or any difficulty breathing are signs of a systemic allergic response. These are rare with tirzepatide, but they are an emergency: call 999 or go to A&E immediately rather than waiting to see how things develop. Your prescriber needs to know afterward, and the medicine should not be used again until you have spoken to them.

A more detailed look at what a tirzepatide injection-site rash can look like in practice, and how to tell the patterns apart, is covered on our page about Mounjaro injection rashes. Redness specifically on the thigh (which is a common injection site for people who prefer not to use the abdomen) has its own considerations, and our thigh injection site guide goes into those.

Practical steps to reduce how often skin reactions happen

There are a few simple adjustments that genuinely make a difference for people who keep seeing local reactions. First, let the pen sit at room temperature for around 30 minutes before you inject, injecting cold fluid from the fridge is harder on the tissue. Second, make sure you are not reusing needles; a fresh needle is sharper and creates less trauma to the skin. Our needle pack is available for exactly this reason. Third, cleaning the skin with an alcohol swab before injecting is good practice, but let it dry completely before the needle goes in.

The injection itself should go smoothly and at the correct angle, the pen's instructions and the Patient Information Leaflet specify the technique; if anything is unclear, your prescriber is the person to ask, not a forum. One detail that catches people out: if you have just changed dose, it is not unusual to see a fresh local reaction at the new pen's first injection. The skin sometimes needs a week or two to settle again. For a broader picture of how to manage the injection process day to day, the Mounjaro injection overview is a useful reference.

If you find yourself wondering whether persistent reactions mean tirzepatide is right for you, or whether a different injection site might help, that is exactly the kind of thing to bring to a prescriber review. Information on the wider context of Mounjaro treatment (including how the clinical review process works at each repeat) is on our Mounjaro treatment page.

Reporting reactions and getting the right support

The UK has a formal system for reporting suspected side effects from prescription medicines: the MHRA's Yellow Card scheme. You do not need a confirmed diagnosis to report, a suspected link is enough. If you experienced an unexpected or significant skin reaction, reporting it helps build the safety picture for everyone using tirzepatide. Tirzepatide still carries a Black Triangle (▼) status in the UK, meaning regulators are actively collecting this kind of real-world information.

At nume, a real prescriber reads every consultation and every repeat request, not software. If a skin reaction has left you uncertain about continuing, or if you are thinking about starting tirzepatide and want to understand what side effects to look out for, our clinical team is available seven days a week for aftercare queries. The cost of treatment and what is included in a single transparent price is on our Mounjaro cost page, if that is on your mind too. Otherwise, when you are ready to talk to a prescriber about whether tirzepatide is suitable for you, start with a free consultation, no referral needed, reviewed the same day.